Cell Medica signs up for an off-the-shelf CAR-T collaboration with Baylor
Just a few months ago, London-based Cell Medica teamed up with investigators at Baylor College of Medicine in Texas to develop new cell therapies that they felt could overcome the early limitations seen in CAR-T for solid tumors. Now they’ve decided to quickly step up the collaboration and aim straight at an off-the-shelf CAR-T that could rival the personalized treatments nearing regulatory submissions.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.